
MOLN
USDMolecular Partners AG American Depositary Shares
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$4.110
उच्च
$4.265
कम
$3.720
मात्रा
0.01M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
146.2M
उद्योग
जैव प्रौद्योगिकी
देश
Switzerland
ट्रेडिंग आँकड़े
औसत मात्रा
0.00M
एक्सचेंज
NMS
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells co-expressing
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
IND application filed for MP0712, the Company's lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images from MP0712
संबंधित स्टॉक
GHSI
Guardion Health Sciences Inc.
PRPH
ProPhase Labs Inc. (DE)
OPT
Opthea Limited American Depositary Shares
SLGL
Sol-Gel Technologies Ltd. Ordinary Shares
ARCT
Arcturus Therapeutics Holdings Inc.
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।